相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arylboronic acids as dual-action FAAH and TRPV1 ligands
Enrico Morera et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
TRPV1-FAAH-COX: The Couples Game in Pain Treatment
Francesca Aiello et al.
CHEMMEDCHEM (2016)
Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies
Marco Migliore et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain
Natalia Malek et al.
PHARMACOLOGICAL RESEARCH (2016)
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
M. Mecha et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Transient receptor potential vanilloid type 1 antagonists: a patent review (2011-2014)
Yoonji Lee et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage
Oscar Sasso et al.
FASEB JOURNAL (2015)
Peripherally increased artemin is a key regulator of TRPA1/V1 expression in primary afferent neurons
Yasuko Ikeda-Miyagawa et al.
MOLECULAR PAIN (2015)
A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis
Natalia Malek et al.
PAIN (2015)
Polypharmacology Shakes Hands with Complex Aetiopathology
James S. Brodie et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
Natalia Malek et al.
NEURAL PLASTICITY (2015)
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain
Ermelinda Lomazzo et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Peripheral gating of pain signals by endogenous lipid mediators (vol 17, pg 164, 2014)
Daniele Piomelli et al.
NATURE NEUROSCIENCE (2014)
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
Travis W. Grim et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels
Giorgio Ortar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Rationally Designed Multitarget Agents Against Inflammation and Pain
S. H. Hwang et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Non-psychotropic analgesic drugs from the endocannabinoid system: Magic bullet or multiple-target strategies?
Katarzyna Starowicz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate
Carmen La Porta et al.
PAIN (2013)
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism
Katarzyna Starowicz et al.
PLOS ONE (2013)
Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as dual-target analgesics
Sabatino Maione et al.
PHARMACOLOGICAL RESEARCH (2013)
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
Josee Guindon et al.
PHARMACOLOGICAL RESEARCH (2013)
Regulation of mu-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance
John T. Williams et al.
PHARMACOLOGICAL REVIEWS (2013)
Redundancy of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control
Fabiana Piscitelli et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system
Bright N. Okine et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Fatty Acid Amide Hydrolase Inhibitors – Progress and Potential
Ish K. Khanna et al.
CNS & Neurological Disorders-Drug Targets (2012)
Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all
Vincenzo Di Marzo
PAIN (2012)
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
John P. Huggins et al.
PAIN (2012)
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Safety Advantages of Topical versus Oral Nonsteroidal Antiinflammatory Drugs
Roy D. Altman
JOURNAL OF RHEUMATOLOGY (2011)
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats
Vito de Novellis et al.
MOLECULAR PAIN (2011)
A FAAH-fetched approach to treat osteoarthritis pain
Aron H. Lichtman et al.
PAIN (2011)
NSAIDs and risk of lower gastrointestinal bleeding
Elham Rahme et al.
LANCET (2010)
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
Cory C. Toth et al.
MOLECULAR PAIN (2010)
The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice
Barbara Costa et al.
PHARMACOLOGICAL RESEARCH (2010)
Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide Hydrolase
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands
Enrico Morera et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1
C. J. Fowler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Multifunctional Drugs: A Novel Concept for Psychopharmacology
Stephen M. Stahl
CNS SPECTRUMS (2009)
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
S. G. Kinsey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Lipids as targets for novel anti-inflammatory therapies
Andrea Huwiler et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber-Induced Heterosynaptic Pain Sensitization
Alejandro J. Pernia-Andrade et al.
SCIENCE (2009)
Chronic pain and opiates: balancing pain control and risks in long-term opioid treatment
Rollin M. Gallagher et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2008)
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Prostaglandin E-2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NF kappa B activity
S. Shu-Jung Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats
Vito de Novellis et al.
NEUROPHARMACOLOGY (2008)
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain
Maulik D. Jhaveri et al.
NEUROPHARMACOLOGY (2008)
The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level
Gyoengyi Horvath et al.
PAIN (2008)
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Narender R. Gavva et al.
PAIN (2008)
The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action
C. J. Fowler
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
M. D. Jhaveri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
New N-arachidonoylserotonin analogues with potential dual mechanism of action against pain
Giorgio Ortar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways
Katarzyna Starowicz et al.
JOURNAL OF NEUROSCIENCE (2007)
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs
Wayne A. Ray et al.
GASTROENTEROLOGY (2007)
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors
S. Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Leon Chang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH
Ben Paylor et al.
PHARMACOLOGICAL RESEARCH (2006)
The TRPV1 receptor and nociception
David C. Immke et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2006)
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain
Josee Guindon et al.
NEUROPHARMACOLOGY (2006)
Participation of the spinal TRPV1 receptors in formalin-evoked pain transduction: a study using a selective TRPV1 antagonist, iodo-resiniferatoxin
Y Kanai et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors
S Maione et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1
E Lizanecz et al.
MOLECULAR PHARMACOLOGY (2006)
Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain
J Guindon et al.
PAIN (2006)
The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac
A Ulugöl et al.
ANESTHESIA AND ANALGESIA (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
L. Cristino et al.
NEUROSCIENCE (2006)
Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
W Yang et al.
JOURNAL OF LIPID RESEARCH (2005)
TRPV1 desensitisation and endogenous vanilloid involvement in the enhanced analgesia induced by capsaicin in inflamed tissues
A Baamonde et al.
BRAIN RESEARCH BULLETIN (2005)
Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice
K Bölcskei et al.
PAIN (2005)
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
S Holt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
M van der Stelt et al.
EMBO JOURNAL (2005)
Fatty acid amide hydrolase controls mouse intestinal motility in vivo
R Capasso et al.
GASTROENTEROLOGY (2005)
Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels
E de Lago et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist
DM Swanson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inflammatory mediators convert anandamide into a potent activator of the vanilloid type 1 transient receptor potential receptor in nociceptive primary sensory neurons
AS Tahim et al.
NEUROSCIENCE (2005)
[3H]resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution
JC Roberts et al.
BRAIN RESEARCH (2004)
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity
AH Lichtman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin
CJ Fowler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2003)
Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism
K Seidel et al.
NEUROSCIENCE LETTERS (2003)
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications
T Bisogno et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin
S Ito et al.
NEUROSCIENCE RESEARCH (2001)
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
L De Petrocellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
V Di Marzo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
JB Davis et al.
NATURE (2000)
分享论文
